The above article, “Downregulation of microRNA‐1469 promotes the development of breast cancer via targeting HOXA1 and activating PTEN/PI3K/AKT and Wnt/β‐catenin pathways,” by Yonghui Zhang, Jing Fang, Hongmeng Zhao, Yue Yu, Xuchen Cao, and Bin Zhang, J Cell Biochem. 2019; 5097‐5107. The above article, published online on 15 October 2018 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.27786), has been retracted by agreement between the authors, the journal acting Editor‐in‐Chief, Dr. Lucie Kalvodova, and the Wiley Periodicals LLC following an investigation based on public allegations. The authors stated that unintentional errors occurred during the research process, and the experimental results cannot be verified.

中文翻译：

---

研究：microRNA-1469的下调通过靶向HOXA1并激活PTEN / PI3K / AKT和Wnt /β-catenin途径促进乳腺癌的发展

上面的文章“通过靶向HOXA1并激活PTEN / PI3K / AKT和Wnt /β-catenin途径，下调microRNA-1469促进乳腺癌的发展”，作者：张永辉，方静，赵洪孟，于跃，曹旭晨，以及张斌（J Cell Biochem）。2019; 5097-5107。以上文章于2018年10月15日在Wiley在线图书馆（https://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.27786）上在线发布，根据作者的同意，该期刊已撤回，该期刊为代理编辑-首席研究员Lucie Kalvodova博士和Wiley Periodicals LLC在基于公开指控进行调查之后。作者指出，在研究过程中发生了意外错误，并且无法验证实验结果。